Who is the CEO of EDIT? | Glauxie AI

Q: Who is the CEO of EDIT?

Editas Medicine, Inc. (EDIT) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Gilmore O'Neill. Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing... Employees: 20,000.

Q: What does EDIT company do?

Learn what EDIT does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling EDIT?

Track recent insider buys and sells for EDIT with transaction details, amounts, and trends.

Q: What sector is EDIT in?

Find EDIT sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of EDIT?

🦉

Editas Medicine, Inc. (EDIT)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOGilmore O'Neill

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical...

Key Executives

Name	Title
Amy Parison	Senior Vice President & Chief Financial Officer
Brieana Buckley	Senior Vice President of Development and Program Leadership
Cristi Barnett	Senior Vice President of Corporate Communications & Investor Relations
Damien Grierson	Senior Vice President, General Counsel & Corporate Secretary
Feng Zhang	Co-Founder & Scientific Advisory Board Member
Frank Panaccio	Senior Vice President & Chief Business Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

EDIT Profile Financials

What does EDIT company do? Are insiders buying or selling EDIT? What sector is EDIT in?